These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

97 related articles for article (PubMed ID: 9750092)

  • 1. Intranasal influenzavirus vaccine in children.
    Dumois J
    N Engl J Med; 1998 Sep; 339(13):922-3. PubMed ID: 9750092
    [No Abstract]   [Full Text] [Related]  

  • 2. Intranasal influenzavirus vaccine in children.
    Edwards KM; Dupont WD
    N Engl J Med; 1998 Sep; 339(13):922; author reply 922-3. PubMed ID: 9750091
    [No Abstract]   [Full Text] [Related]  

  • 3. Studies with live attenuated influenza vaccines.
    Douglas RG; Betts RF
    Am J Clin Pathol; 1978 Jul; 70(1 Suppl):153-8. PubMed ID: 685888
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Superior relative efficacy of live attenuated influenza vaccine compared with inactivated influenza vaccine in young children with recurrent respiratory tract infections.
    Ashkenazi S; Vertruyen A; Arístegui J; Esposito S; McKeith DD; Klemola T; Biolek J; Kühr J; Bujnowski T; Desgrandchamps D; Cheng SM; Skinner J; Gruber WC; Forrest BD;
    Pediatr Infect Dis J; 2006 Oct; 25(10):870-9. PubMed ID: 17006279
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Live attenuated influenza vaccine in children.
    Ambrose CS; Walker RE; Connor EM
    Semin Pediatr Infect Dis; 2006 Oct; 17(4):206-12. PubMed ID: 17055372
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Importance of influenza in the child. Intranasal influenza vaccine: another systematic vaccination?].
    Moraga Llop FA; Campins Martí M
    An Esp Pediatr; 2000 Oct; 53(4):299-304. PubMed ID: 11523509
    [No Abstract]   [Full Text] [Related]  

  • 7. Trivalent live attenuated intranasal influenza vaccine administered during the 2003-2004 influenza type A (H3N2) outbreak provided immediate, direct, and indirect protection in children.
    Piedra PA; Gaglani MJ; Kozinetz CA; Herschler GB; Fewlass C; Harvey D; Zimmerman N; Glezen WP
    Pediatrics; 2007 Sep; 120(3):e553-64. PubMed ID: 17698577
    [TBL] [Abstract][Full Text] [Related]  

  • 8. FluMist: an intranasal live influenza vaccine.
    Med Lett Drugs Ther; 2003 Aug; 45(1163):65-6. PubMed ID: 12915803
    [No Abstract]   [Full Text] [Related]  

  • 9. Cold-adapted, live attenuated intranasal influenza virus vaccine.
    Zangwill KM
    Pediatr Infect Dis J; 2003 Mar; 22(3):273-4. PubMed ID: 12634591
    [No Abstract]   [Full Text] [Related]  

  • 10. Safety, immunogenicity and efficacy of intranasal, live attenuated influenza vaccine.
    Belshe R; Lee MS; Walker RE; Stoddard J; Mendelman PM
    Expert Rev Vaccines; 2004 Dec; 3(6):643-54. PubMed ID: 15606348
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comparison of the efficacy and safety of live attenuated cold-adapted influenza vaccine, trivalent, with trivalent inactivated influenza virus vaccine in children and adolescents with asthma.
    Fleming DM; Crovari P; Wahn U; Klemola T; Schlesinger Y; Langussis A; Øymar K; Garcia ML; Krygier A; Costa H; Heininger U; Pregaldien JL; Cheng SM; Skinner J; Razmpour A; Saville M; Gruber WC; Forrest B;
    Pediatr Infect Dis J; 2006 Oct; 25(10):860-9. PubMed ID: 17006278
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Evaluation of an attenuated, live, bivalent, influenza vaccine in children.
    Burech DL; Koranyi KI; Haynes RE
    Ohio State Med J; 1976 Jul; 72(7):385-7. PubMed ID: 934582
    [No Abstract]   [Full Text] [Related]  

  • 13. Cross-reactive H1N1 antibody responses to a live attenuated influenza vaccine in children: implication for selection of vaccine strains.
    Lee MS; Yang CF
    J Infect Dis; 2003 Nov; 188(9):1362-6. PubMed ID: 14593595
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Influenza vaccine 2005-2006.
    Med Lett Drugs Ther; 2005 Oct; 47(1220):85-7. PubMed ID: 16264371
    [No Abstract]   [Full Text] [Related]  

  • 15. Nasal influenza vaccine enters Phase I clinical trial.
    Expert Rev Vaccines; 2007 Jun; 6(3):305. PubMed ID: 17542745
    [No Abstract]   [Full Text] [Related]  

  • 16. Prevention and treatment of influenza infections.
    Iacuzio D
    Adv Intern Med; 2001; 46():51-76. PubMed ID: 11147260
    [No Abstract]   [Full Text] [Related]  

  • 17. Efficacy and safety of 1 and 2 doses of live attenuated influenza vaccine in vaccine-naive children.
    Bracco Neto H; Farhat CK; Tregnaghi MW; Madhi SA; Razmpour A; Palladino G; Small MG; Gruber WC; Forrest BD;
    Pediatr Infect Dis J; 2009 May; 28(5):365-71. PubMed ID: 19395948
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Serum and mucosal immunologic responses in children following the administration of a new inactivated intranasal anti-influenza vaccine.
    Greenbaum E; Furst A; Kiderman A; Stewart B; Levy R; Schlesinger M; Morag A; Zakay-Rones Z
    J Med Virol; 2001 Sep; 65(1):178-84. PubMed ID: 11505461
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A one-size-fits-all flu vaccine?
    Kaiser J
    Science; 2006 Apr; 312(5772):380-2. PubMed ID: 16627732
    [No Abstract]   [Full Text] [Related]  

  • 20. Safety and tolerability of cold-adapted influenza vaccine, trivalent, in infants younger than 6 months of age.
    Vesikari T; Karvonen A; Smith HM; Dunning A; Razmpour A; Saville MK; Gruber WC; Forrest BD
    Pediatrics; 2008 Mar; 121(3):e568-73. PubMed ID: 18299305
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.